Welcome to International Academy of Cardiovascular Sciences (HEARTACADEMY.ORG)

IACS elects five outstanding new Fellows

Dr. C. Noel Bairey Merz

C . Noel Bairey Merz, MD, holds the Women’s Guild Endowed Chair in Women’s Health, and is Director of the Women’s Heart Center and the Preventive and Rehabilitative Cardiac Center in the Cedars-Sinai Heart Institute where she is a Professor of Medicine .

Dr . Bairey Merz’s research interests include women and heart disease, mental stress and heart disease, the role of exercise and stress management in reversing disease, and the role of nutrition in heart disease . Currently, she is chair of the National Institutes of Health (NIH)-sponsored WISE (Women’s Ischemic Syndrome Evaluation) initiative . Dr . Bairey Merz has received investigational grants from the NIH-National Heart, Lung and Blood Institute (NHLBI), NIH-National Center for Alternative and Complementary Medicine (NCCAM), the Pfeiffer Foundation, The Eli and Edythe Broad Foundation, The Barbra Streisand Foundation, and the Women’s Guild .

A prolific lecturer, Dr . Bairey Merz, is a member of many professional organizations and served on the Board of Trustees of the American College of Cardiology (ACC), as well as the American Heart Association where she is past Chair of the Women in Cardiology Committee . Other professional associations include membership in the Association of University Cardiologists (AUC), the American Association of Physicians (AAP), the National Space Biomedical Research Institute Board of Scientific Counselors, and the National Cholesterol Education Program, Adult Treatment Panel IV . She serves on the advisory boards of lay organizations, including WomenHeart and Sister-to-Sister .

Bairey Merz has an extensive scientific publication record consisting of over 500 scientific publications . Her work has been published in numerous peer-reviewed journals including the New England Journal of Medicine, the Journal of the American Medical Association, Circulation, the Journal of the American College of Cardiology, and the Journal of Women’s Health .

Dr . Bairey Merz has received numerous awards and honors, including the 2012 American College of Cardiology Distinguished Scientist Award, the 2009 American Heart Association Women in Cardiology Mentoring Award, the 2008 McCue Female Cardiologist of the Year Award, the 2005 Red Dress Award for Leadership in Cardiovascular Research in Women, the 2005 Women of the 21st Century award from the Women’s Guild of Cedars-Sinai Medical Center, and the 2006 Alvin P . Shapiro Award by Psychosomatic Society for excellence in clinical research .

Dr . Bairey Merz has appeared frequently in the media, recognized as an authority on the subject of heart disease and stress . Her television appearances have included Good Morning America, NBC Dateline and 20/20 . She has also been interviewed for articles published in The New York Times, Ladies Home Journal, US News & World Report and Working Woman Magazine, to name a few . Dr . Bairey Merz received her bachelor’s degree from the University of Chicago and her medical degree from Harvard University . She completed her residency at the University of California, San Francisco, where she served as Chief Medical Resident . Dr . Bairey Merz also completed fellowships in clinical cardiology and nuclear cardiology at Cedars-Sinai Medical Center .

We have added from our web site a link to an incredible talk, including the introduction by Barbra Streisand - http://tedxwomen.org/speakers/noel-bairey-merz

Dr. R.C.Sobti

Prof . Ranbir Chander Sobti is a well-known scientist in the area of biotechnology; the Vice Chancellor of the Babasaheb Bhimrao Ambedkar University in Lucknow; former Vice Chancellor of the Panjab University, Chandigarh; and the President of the Indian Science Congress (2013-14) .

Professor Sobti began his teaching career in the Department of Zoology, Panjab University in 1976 and went on to become the founder-Chairperson of the Biotechnology Department as a Professor of Cell Biology . Currently he has over 246 publications and 22 books to his credit . His research work, particularly in the areas of cancer and environmental Biology, has more than 1100 citations with an ‘h’ index 18 (Citation gadget) and has seen him head or be a part of the editorial boards of respected national and international journals such as Molecular Cell Biochemistry, Cytology and Genetics, Indian Journal of Human Genetics etc . for policy-driven research in genetic markers and cancer-environment linkages .

Prof Sobti has received 26 awards and 16 fellowships . He has supervised 44 PhDs and is currently working on eight others . He has 25 books published . He is the Fellow of the Indian National Science Academy, National Academy of Sciences, National Academy of Medical Science, National Academy of Agricultural Sciences, Indian Society of Cytologists & Geneticists . He has recently been awarded the D .Sc . degree as notified by Himachal Pradesh University .

His contribution as a ground-breaking biotechnologist, skilled orator, efficient administrator and futuristic Vice-Chancellor has won him accolades at both the national and the international levels a fact recognized by the Government of India while honoring him with one of the highest civilian award in India the Padma Shree in 2009 .

During his Vice chancellorship, Prof . Sobti focused on creating a world class academic infrastructure and a conducive work environment for research while at the same time safeguarding the principle of equity by ensuring that education remained both inclusive and affordable . Affirmative action was taken by establishing Regional Centres and Constituent Colleges in rural areas; creation of special seats for the Single Girl Child, Cancer, AIDS and cardiac patients, not just on campus but also in the 188 affiliated colleges; and free education for orphans and specially-abled students . He also spearheaded the move to adopt 8 peripheral villages of Chandigarh in order to improve their acutely attuned to the importance of environment because of his work in cancer biology .

Dr. Tejal R. Gandhi

Dr . Tejal R . Gandhi is a senior Research Scientist and Academician, with over 20 years of experience in Pharmaceutical Research, particularly in the areas of Cardiovascular and Metabolic Disorders .

After obtaining B .Pharm . in 1990, Dr . Gandhi did her research work at the L M College of Pharmacy, the leading Pharmacy Institute of Asia, under the guidance of Prof . Ramesh K . Goyal . During the course of her research work, Dr . Gandhi was selected as a Senior Research Fellow with the Council of Scientific and Industrial Research, a Government of India-sponsored Research Institute . Her research work at the L M College of Pharmacy and with the CSIR, led her to conduct research on “Effect of newer A .C .E . Inhibitors and Calcium Channel Blockers in cardiovascular complications associated with Diabetes Mellitus and Hypertension” .

Dr . Gandhi also played a lead role in the development of a new molecule for treatment of hyperlipidaemia . As a result of the efforts of this research team, with QSAR techniques, a new molecule LM-1554 was synthesised and pharmacokinetic, pharmacodynamic and mechanism of action of this new cholesterol-lowering agent was investigated .

Dr . Gandhi joined the Anand Pharmacy College as Assistant Professor in 1999, and was subsequently promoted to the post of Professor & Head of the Institute . The Research Centre focuses on collaborative research, wherein a number of research programs are being conducted in collaboration with a number of leading pharmaceutical companies . Dr . Gandhi oversees an active research team of 20, comprising of Doctoral Fellows, Post-graduate students, Associate & Assistant Professors, and Research Technicians . The research facility places emphasis on finding new synthetic molecules, particularly for use as antihyperlipaemic and antihypertensive agents with beta1 adrenoceptor antagonist with beta2 adrenoceptor agonist activity . Over the last one decade, Dr . Gandhi has been involved in the search of new molecules with herbal origin, beneficial to cardiovascular patients and nephrolithiatic patients . Under her leadership, the research team in her Institute laboratory has been involved in the development of analytical methods for the same . One patent has already been published to her credit . She has published more than 70 research papers in International and National Journals covering various aspects of Pharmaceutical Sciences .

This state-of-the-art research facility at the Institute for advanced research in pharmaceutical sciences, including cardiovascular diseases and metabolic disorders was inaugurated by Prof . Naranjan S . Dhalla in 2011 during the 4thWorld Congress of the I A C S . In fact she was the organizing secretary for the I A C S Conference in Anand, India in collaboration of M .S . University, Baroda .

Dr . Gandhi places great importance on grooming the next generation .She is the recipient of the “2011 R V Patel Research Guide Award”, an accolade that recognizes excellence in overall research training to the post-graduate students of M Pharm program in Gujarat state, sponsored by Troikaa Pharmaceuticals . Recently she has also been the recipient of Pedagogical Innovation Award 13 for continuing efforts towards Innovation Pedagogies at various levels by GTU innovation Council .

Dr . Gandhi has, to date, mentored over 50 Post-graduate students and 6 Doctoral Fellows on their research projects . Several of them having been recipients of prestigious national-level research awards, including the Gandhian Young Innovation Award 2013, GUFIC Prize (2006 & 2008) for Best Research in Pharmacology and S C Verma Memorial Prize for Best Research Presentation in Gujarat state (2008, 2009 & 2010) .

Dr . Gandhi has also actively participated in successfully organizing a number of Diabetes & Hypertension Camps, for free checkups and guidance for underprivileged people in Gujarat State . She was a key contributor to Project India with Operation Diabetes and the international pharmaceutical students, Federation of the University of Southern California, School of Pharmacy .

Dr. Sharon L. Mulvagh

Dr . Mulvagh is Professor of Medicine, Mayo College of Medicine, and Consultant in Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota . She is a clinical cardiologist, echocardiographer and Director of the Mayo Clinic Women’s Heart Clinic . She is an active clinician investigator engaged in imaging research, and an internationally recognized educator and speaker on cardiovascular imaging and women’s cardiovascular issues . Dr . Mulvagh has ongoing studies investigating the role of noninvasive testing for the diagnosis of coronary heart disease in women using newer technologies including contrast echocardiography and myocardial perfusion imaging . She is an avid proponent of preventive cardiology and cardiovascular risk management and is the principal investigator for clinical trials involving novel approaches to weight loss for cardiovascular risk reduction, and early detection of chemotherapy-induced cardiomyopathy .

She earned her doctorate in medicine, graduating magna cum laude, from the University of Ottawa, Ottawa, Canada, her hometown . She completed her internship at Dalhousie University in Halifax, Nova Scotia, residency in internal medicine at Boston University Medical Center, Boston, MA, and fellowship in cardiology at Baylor College of Medicine in Houston, TX . She has practiced emergency and internal medicine in Ontario, Canada, and was a visiting scientist at NASA Johnson Space Center, and Clinical Instructor for Baylor College of Medicine in Houston, TX, prior to arriving at Mayo Clinic in 1990 .

Dr . Mulvagh is a fellow of the American College of Cardiology, the American Heart Association Council on Clinical Cardiology, the American Society of Echocardiography, and the Royal College of Physicians and Surgeons of Canada . She is an elected member of Sigma Xi, and has served on the Board of Directors for the American Society of Echocardiography . She is certified in Adult Comprehensive Echocardiography by the National Board of Echocardiography . She has chaired and participated in numerous committees including the American Society of Echocardiography Task Force for Clinical Applications of Ultrasound Contrast, Committee on Live Programs, Research Awards, and Nominating Committees . In addition she has served on NASA Scientific Working Groups and Peer Review sessions . She has over a hundred publications including manuscripts in peer-reviewed journals and invited articles and book chapters addressing investigative frontiers in echocardiography, and women and heart disease . Over the past two decades, she has been a manuscript reviewer for all of the major cardiovascular journals, and has served as abstract reviewer, speaker, moderator and chair for many scientific sessions for the American College of Cardiology, the American Society of Echocardiography, and the American Heart Association . She was the medical chair for the First Inaugural Rochester Go Red For Women American Heart Association Luncheon in 2007, and was the keynote speaker again in 2013 . She also served as the keynote speaker for the Women’s Heart Health Initiative program launched at St . Boniface Hospital in Winnipeg, MN in 2013, where she also delivered the International Academy of Cardiovascular Sciences Harold Buchwald Memorial Lecture in 2011 .

Dr. Mulvagh’s outstanding talk in Wiinipeg, the 3rd Harold Buchwald Heart Health Lecture, is online: http://www.sbrc. tv/1/watch/180.aspx

Dr. Ferid Murad

Dr . Murad completed his undergraduate work at DePauw University and received his MD and PhD from Case Western Reserve University . He had a medical residency at Massachusetts General Hospital and a fellowship at National Institutes of Health . He was on the faculty at the University of Virginia (1970-1981) as Director of the Clinical Research Center and Director of the Division of Clinical Pharmacology with appointments in Medicine and Pharmacology . He was Chief of Medicine at Palo Alto Veterans Hospital {1981- 1988), Associate Chairman of Medicine (1982-1986) and Chairman of Medicine (1986-1988) at Stanford University . He was Vice President of Research and Development at Abbott Laboratories {1988-1993) and Professor at Northwestern University . Dr . Murad worked at the University of Texas Health Science Center at Houston as Chairman of Department of Integra tive Biology and Pharmacology at Medical School (1997-2005) and as Director (1999-2007) and Director Emeritus (2007-2011) of Institute of Molecular Medicine . From 2011 to present, he has been a University Professor at George Washington University, and Director of the Institute for Cell Signaling .

Dr . Murad has been active in both academic medicine and industry throughout his distinguished career . He has founded or co-founded eight biotechnology companies and has advised many cities and government leaders about technology development . His work has concentrated on the field of cell signaling and signal transduction systems .

In 1998, Dr .Murad received the Nobel Prize in Medicine for his work with nitric oxide, a colorless odorless gas that signals blood vessels to relax and widen, which in turns lowers blood pressure . He continues research which leads to a better understanding of how information is transmitted between the cells . Among his many awards and honors, Dr . Murad received the prestigious Albert and Mary Lasker basic Medical Research Award in 1996, the American Heart Association Ciba award in 1988, and the Baxter Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges in 2000 . He also received the American Society of Clinical Pharmacology Distinguished Research Prize in 2005 and the President’s Scholar Award from the University of Texas- Houston Health Science Center in 2006 .

He is a member of the National Academy of Sciences, a member of the Institute of Medicine, Fellow of the American Academy of Arts and Sciences, and a member of many foreign academies as well as an Honorary or Adjunct Professor at a number of universities . Dr . Murad also serves on the Board of Directors or Scientific Advisory Boards of a number of public and private companies and various foundations and universities . He has received 17 honorary degrees and has published 450 manuscripts and authored or edited 28 books . About 150 trainees have worked with him in his laboratories who are currently academic or pharmaceutical industry leaders around the world .

World-renowned Research Centre renamed

St-Boniface Hospital honoured Winnipeg visionary and philanthropist Paul Albrechtsen by renaming its Research Centre the St-Boniface Hospital Albrechtsen Research Centre. The Centre is the global headquarters of the International Academy of Cardiovascular Sciences where our Dr. Naranjan Dhalla was the founder of the Institute of Cardiovascular Sciences.

He was interviewed recently by the American Physiological Society's for their "Living History Program.

Click here to enjoy


3rd Harold Buchwald Lecture by Dr. Sharon Mulvagh, Mayo Clinic, Rochester


Click for An Important Conversation About Heart Health between Dr. Mulvagh and Marlo Thomas

If you missed the MANSHIELD CONSTRUCTION HEART HEALTH LUNCHEON featuring the 5th Harold Buchwald Lecture on October 3, 2013, please Click here for Dr Yusuf's extraordinary talk

Dr. Robert Roberts made a very special talk as the first Yetta and Jack Levit Distinguished Lecture. Click here to enjoy Dr. Roberts ' talk. On Nov. 2/15, Dr. John Cairns second Distinguished Lecture was extraordinary Click here for the lecture.

2nd Harold Buchwald Heart Health Lecture Sept. 29, 2009 ... an incredible talk by Dr. Jay Cohn which inspired Ivan Berkowitz to pursue a number of options which led to Dr. Duhamel's HAPPY Hearts Project. Click here to watch video

Read the latest bulletin from St. Boniface - excellent reports on IACS Fellows Drs. Menkis, Pierce and Kirshenbaum - great heart health advice!